The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Reactive airway dysfunction syndrome (RADS)
Publications
Chemical Pneumonitis and Reactive Airways Dysfunction Syndrome After Fumigation Exposure to Dimethanol and Glutaraldehyde: A Silent Menace Unmasked.
Cureus 2023 Aug;15;e42939 — 2023 Aug — e42939
A 27-Year-Old Man With Persistent Breathlessness After an Inhalational Injury.
Chest 2021 Apr;159;e197-e201 — 2021 Apr — e197-e201
Chronic pulmonary dysfunction following acute inhalation of butyl acrylate.
The West Virginia medical journal 2012 Nov-Dec;108;28-32 — 2012 Nov-Dec — 28-32
Chemical pneumonitis and subsequent reactive airways dysfunction syndrome after a single exposure to a household product: a case report.
Journal of medical case reports 2009 Nov 09;3;112 — 2009 Nov 09 — 112
Severe airway disease due to inhalation of fumes from cleansing agents.
Chest 1976 Mar;69;372-6 — 1976 Mar — 372-6